Neil Woodford’s High Income Fund Farewell: Wm. Morrison Supermarkets plc, Rentokil Initial plc And Sanofi SA

Woodford’s mega-million moves on Wm. Morrison Supermarkets plc (LON:MRW), Rentokil Initial plc (LON:RTO) and Sanofi SA (NYSE:SNY).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Neil Woodford announced last October that he was calling time on his quarter-century career with asset management group Invesco Perpetual. Britain’s most celebrated money manager handed over control of his Invesco funds last month, and will shortly launch his own equity income vehicle from his new Woodford Investment Management business.

Invesco has just published the final annual report under Woodford’s tenure of the £13.5bn flagship High Income fund. The report reveals some of the City wizard’s last mega-million moves for the fund, including big trades in Wm. Morrison Supermarkets (LSE: MRW), Rentokil Initial (LSE: RTO) and Sanofi (NYSE: SNY.US).

Woodford’s share buys and sells during the first half of the year were balanced. However, the second half of the year saw net sales of around £1bn, as Woodford paid out to investors who pulled out of the fund after the announcement of his departure.

We saw a trimming of many holdings to raise the £1bn, but there were also some large positions that Woodford exited completely.

Wm. Morrison Supermarkets

Woodford disposed of the High Income fund’s 68.4 million shares in Morrisons, raising a whopping £187m. The numbers give a sale price of about 273p a share. Whether Woodford had become disillusioned with his former supermarket favourite, or was getting shot of a company his successor wasn’t keen on, is a moot point.

Either way, it was a timely sale, as the shares are currently trading at not much more than 200p — representing 14 times forecast earnings with a potential income of 6.5%.

It will be interesting to see whether Woodford buys back into Morrisons for his new fund. I see the supermarket as being in a similar position to AstraZeneca a couple of years ago, when the contrarian Woodford was piling into the then-unloved pharmaceuticals firm.

Rentokil Initial

Rentokil, which has a wider range of hygiene businesses than the soubriquet ‘royal rat catcher’ suggests, is another holding Woodford has binned. The sale of the High Income fund’s substantial stake in the mid-cap firm raised £117m. My sums say Woodford sold at about 105p a share, compared with 116p today.

Like Morrisons, Rentokil trades on a forward P/E of 14, but the prospective dividend yield is much lower at 2.2%. Woodford originally bought into Rentokil as “a significant restructuring opportunity”. The bulk of the restructuring has been done, and it remains to be seen whether Woodford thinks the story has further to run and buys back into Rentokil for his new fund.

Sanofi

Given the outflow of money from the High Income fund, and the net £1bn of share sales to cover the redemptions, I was surprised to find Woodford actually increasing the fund’s stake in some companies.

Woodford added modestly to a few of his Footsie favourites, including Imperial Tobacco, GlaxoSmithKline and Centrica, but substantially upped the fund’s stake in French drugs giant Sanofi. He increased the holding by almost 50% during the course of the year, spending in the region of £100m.

The Paris-listed company, which can also be traded on the New York stock exchange, is on a forward P/E of 14 — the same as FTSE counterpart GlaxoSmithKline. Analysts have Sanofi delivering faster earnings growth over the next couple of years, but GlaxoSmithKline offering a higher dividend.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester does not own any shares mentioned in this article. The Motley Fool has recommended shares in Morrisons and GlaxoSmithKline.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »